MAO inhibitors and platelet MAO inhibition

Comparative Study

E Giller Jr et al. Commun Psychopharmacol. 1980.

. 1980;4(1):79-82.

No abstract available

Similar articles

Haloperidol inhibition of monoamine oxidase in vivo and in vitro.
Giller E, Hall H, Reubens L, Wojciechoswki J. Giller E, et al. Biol Psychiatry. 1984 Apr;19(4):517-23. Biol Psychiatry. 1984. PMID: 6733172
Platelet enzyme abnormalities in neuropsychiatric disease.
Farmer PM. Farmer PM. Ann Clin Lab Sci. 1980 Jul-Aug;10(4):263-8. Ann Clin Lab Sci. 1980. PMID: 6108742
Acute versus chronic effects of monoamine oxidase inhibitors in depressed patients: time course of MAO inhibitors [proceedings].
Robinson DS, Nies A, Ravaris CL. Robinson DS, et al. Psychopharmacol Bull. 1977 Jan;13(1):50-1. Psychopharmacol Bull. 1977. PMID: 319474 Clinical Trial. No abstract available.
Platelet monoamine oxidase, personality and alcoholism: the rise, fall and resurrection.
Oreland L. Oreland L. Neurotoxicology. 2004 Jan;25(1-2):79-89. doi: 10.1016/S0161-813X(03)00115-3. Neurotoxicology. 2004. PMID: 14697883 Review.
Monoamine oxidase-B, monoamine oxidase-B inhibitors, and Parkinson's disease. A role for superoxide dismutase?
Sandler M, Glover V, Clow A, Jarman J. Sandler M, et al. Adv Neurol. 1993;60:238-41. Adv Neurol. 1993. PMID: 8420141 Review. No abstract available.

Insights into the mechanisms of action of the MAO inhibitors phenelzine and tranylcypromine: a review.
Baker GB, Coutts RT, McKenna KF, Sherry-McKenna RL. Baker GB, et al. J Psychiatry Neurosci. 1992 Nov;17(5):206-14. J Psychiatry Neurosci. 1992. PMID: 1362653 Free PMC article. Review.